Study record managers: refer to the Data Element Definitions if submitting registration or results information.
|1||NCT01770301||Active, not recruiting||Efficacy and Safety of Bevacizumab (Avastin®) Combined to Weekly Paclitaxel Followed by Bevacizumab (Avastin®) Alone in Patients With Relapsed Ovarian Sex-cord Stromal Tumours (ALIENOR)||
||Other / Industry||
||60||Female||18 Years and older (Adult, Older Adult)||NCT01770301||ALIENOR (GINECO-OV222)||ALIENOR||February 2013||December 2017||January 2021||January 17, 2013||June 28, 2018||
|Bevacizumab in Treating Patients With Recurrent Sex Cord-Stromal Tumors of the Ovary||
||NIH / Other||
||36||Female||18 Years and older (Adult, Older Adult)||NCT00748657||NCI-2009-00611
|September 22, 2008||January 31, 2013||January 31, 2013||September 8, 2008||July 23, 2019||June 10, 2015||